Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001062993-14-003434
Filing Date
2014-05-30
Accepted
2014-05-29 17:39:17
Documents
9
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A form10qa.htm 10-Q/A 560278
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 4333
3 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 3279
  Complete submission text file 0001062993-14-003434.txt   7780796

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE avxl-20140331.xml EX-101.INS 617094
5 XBRL SCHEMA FILE avxl-20140331.xsd EX-101.SCH 248345
6 XBRL CALCULATION FILE avxl-20140331_cal.xml EX-101.CAL 39608
7 XBRL DEFINITION FILE avxl-20140331_def.xml EX-101.DEF 622261
8 XBRL LABEL FILE avxl-20140331_lab.xml EX-101.LAB 1630433
9 XBRL PRESENTATION FILE avxl-20140331_pre.xml EX-101.PRE 685533
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 000-51652 | Film No.: 14877223
SIC: 8731 Services-Commercial Physical & Biological Research